XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three-month periods ended March 31, 2022 and 2021, were as follows (in thousands):

​

​

​

​

​

​

​

​

    

Three Months Ended

​

    

March 31, 

​

    

2022

    

2021

Net Sales

 

​

  

 

​

  

Cardiovascular

​

$

266,936

​

$

241,006

Endoscopy

​

 

8,479

​

 

7,907

Total net sales

​

 

275,415

​

 

248,913

​

​

​

​

​

​

​

Operating Income

​

 

  

​

 

  

Cardiovascular

​

 

13,126

​

 

12,201

Endoscopy

​

 

2,107

​

 

1,993

Total operating income

​

 

15,233

​

 

14,194

​

​

​

​

​

​

​

Total other expense - net

​

 

(1,062)

​

 

(1,500)

Income tax expense

​

 

3,626

​

 

1,736

​

​

​

​

​

​

​

Net income

​

$

10,545

​

$

10,958